Diabetes and obesity boom will propel Lilly, Novo to front of pharma sales pack by 2030: Evaluate

Fueled by sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin, according to data analytics specialist Evaluate Pharma in its 2030 projection.

Jun 23, 2025 - 15:05
 0
Diabetes and obesity boom will propel Lilly, Novo to front of pharma sales pack by 2030: Evaluate
Fueled by sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin, according to data analytics specialist Evaluate Pharma in its 2030 projection.